Coral Laboratories Limited manufactures and sells pharmaceutical formulations in India, Ethopia, and internationally. The company offers antibiotics/antibacterial products, including antifungal, gastro-intestinal drugs, antiemetic, analgesics/antipyretic/anti-inflammatory, antispasmodic, muscle relaxants, cough suppressant/expectorant products, anticold, antiallergic, anti-asthmatic, cardiovascular medicines, anti-diabetic, anthelmentic, anti-protozoal/anti-amebic products, antimalarial drugs, antipsychotic drugs, thyroid, and kits, oral antiseptic preparations, mouthwashes; nutritional, protein, and iron supplements, calcium preparations, appetizers; and other products. It also offers cephalosporin, beta lactam, and lyophilized injectable products; eye/ear/nose drops; nasal sprays and metered dose inhales; and large volume parenteral products. In addition, the company offers various nutraceutical products, such as dietary supplements, herbal/phytochemicals, multivitamins, and nutrients, as well as OTC products. Further, the company provides its products in various dosage forms, including tablets, capsules, liquid orals, liquids and powders, dry syrups, eye/ear drops, ointment and creams, gels and lotions, B-lactam, low RH facilities, granules powder, injectables, nasal sprays, and suppositories. Coral Laboratories Limited was incorporated in 1994 and is headquartered in Mumbai, India.
Metrics to compare | CORL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCORLPeersSector | |
---|---|---|---|---|
P/E Ratio | 8.5x | 35.9x | −0.5x | |
PEG Ratio | 0.16 | 0.24 | 0.00 | |
Price/Book | 1.0x | 3.5x | 2.6x | |
Price / LTM Sales | 1.8x | 3.9x | 3.3x | |
Upside (Analyst Target) | - | 13.3% | 43.5% | |
Fair Value Upside | Unlock | 9.6% | 6.9% | Unlock |